HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phase II study of spirohydantoin mustard for the treatment of recurrent malignant gliomas.

AuthorsM Prados, L Rodriguez, M Seager, P Silver, V Levin
JournalCancer treatment reports (Cancer Treat Rep) Vol. 71 Issue 11 Pg. 1105-6 (Nov 1987) ISSN: 0361-5960 [Print] United States
PMID3119204 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Hydantoins
  • Nitrogen Mustard Compounds
  • Physostigmine
  • spiromustine
Topics
  • Adult
  • Brain Neoplasms (drug therapy)
  • Diagnosis-Related Groups
  • Drug Evaluation
  • Female
  • Glioma (drug therapy)
  • Humans
  • Hydantoins (therapeutic use)
  • Male
  • Middle Aged
  • Nitrogen Mustard Compounds (therapeutic use)
  • Physostigmine (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: